Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?

benzinga.com/general/biotech/25/05/45199025/why-is-israel-based-generic-drug-focused-teva-pharmaceutical-stock-trading-higher-on-monday

The U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Alvotech’s (NASDAQ:ALVO) Selarsdi (ustekinumab-aekn) injection as interchangeable with the reference biologic Johnson & Johnson’s (NYSE:JNJ) Stelara (ustekinumab).
As of April 30,…

This story appeared on benzinga.com, 2025-05-05 15:43:05.
The Entire Business World on a Single Page. Free to Use →